chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vision loss; Graves' disease; Graves' ophthalmopathy; double vision; tremors; fatigue; tachycardia; increased anxiety; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unspecified age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 24-MA-2016R, patient was inoculated with zoster vaccine live (ZOSTAVAX) vaccine at a pharmacy for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Within several weeks after receiving zoster vaccine live (ZOSTAVAX) vaccine, patient experienced severe and debilitating injuries, including, but not limited to, double vision, vision loss, tremors, fatigue, tachycardia, increased anxiety, Graves' disease and Graves' ophthalmopathy. All of these injuries were caused by zoster vaccine live (ZOSTAVAX) and resulted in extreme pain, discomfort and medical care and multiple procedures and surgeries. As a direct and proximate result of Company's defective zoster vaccine live (ZOSTAVAX) vaccine, patient suffered severe injuries and disfigurement not present prior to using Company's product, which were directly caused by the zoster vaccine live (ZOSTAVAX) vaccine. Patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), patient sustained severe and disfiguring personal injuries. Further, as a tragic consequence of Company's wrongful conduct, patient suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Company's conduct, patient have suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was unknown.  Upon internal review, the events of blindness, endocrine ophthalmopathy and basedow's disease were considered to be medically significant.
13 Weeks Pregnant received the vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (13 Weeks Pregnant received the vaccine) in a 38-year-old female patient (gravida 7, para 4) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included Miscarriage in April 2018 and Miscarriage in March 2019. Concurrent medical conditions included Migraine since 1992 and Penicillin allergy (also allergic to cephalosporin.). Concomitant products included PARACETAMOL (TYLENOL) for Headache, PRENATAL + DHA for Pregnancy.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 23-Nov-2020 and the estimated date of delivery was 19-Sep-2021. On 10-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (13 Weeks Pregnant received the vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifteenth week of the pregnancy.  On 10-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (13 Weeks Pregnant received the vaccine) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, Pregnancy test: positive (Positive) Positive. In 2021, Ultrasound foetal: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported. Patient had 4 Live pregnancies previously and 2 miscarriages in Apr 2018 and Mar 2019. Estimated conception-2020 NICT was performed in Feb 2021 and results were normal.
PAIN ON THE INJECTION SITE; DIARRHEA; FATIGUE; NAUSEA; This spontaneous report received from a patient concerned a 51-year-old male. The patient's weight, height, and medical history were not reported. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of admin not reported, batch number: 1808978,and expiry: 13-JUN-2021) dose was not reported, administered on 25-MAR-2021 in right deltoid for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced diarrhea. On MAR-2021, the subject experienced fatigue. On MAR-2021, the subject experienced nausea. Treatment medications included: Ibuprofen. On 25-MAR-2021, the subject experienced pain on the injection site. The action taken with COVID-19 VACCINE AD26.COV2.S was not applicable. The patient recovered from pain on the injection site on 26-MAR-2021, and had not recovered from fatigue, diarrhea, and nausea. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Coughing, then in evening very sore throat. Tuesday body aches, headache, low grade fever. Did not check as was taking Ibp. for sore throat. Had NO physical symptoms prior to Monday 10/26.
Pt became fussy after shot and while mom consoling infant, she went limp in arms and unable to wake infant. Infant to Dr's office at 6PM and mom status Dr state infant had reaction to Dtap and not to be vaccinated with it again. 10PM baby unable to Dr awakened again to ER awake to OK at 5AM.
PATIENT STATES TO HAVE SORENESS TO ARM, PAIN TO UNDERARM, REDNESS AND WARMTH TO INJECTION SITE. PATIENT STATES SHE HAS BEEN TAKING IBUPROFEN WHICH RELIEVES DISCOMFORT.  PATIENT HAS NOT SEEKED MEDICAL ATTENTION DUE TO HAVING NO INSURANCE AT THIS TIME.
Recurrent Urticaria - at first was daily x 2-3 weeks. Now is about once or twice a week persistently since 2nd vaccine.  Hives resolve with Zyrtec
Tested positive with COVID/ diagnosed with Covid-19; Tested positive with COVID/ diagnosed with Covid-19; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular in right deltoid on 04Jan2021 at a single dose for covid-19 prophylaxis in a hospital at the age of 52 years old. Medical history included ongoing type 2 diabetes mellitus diagnosed 13 years ago (unspecified date).  The patient's concomitant medications were not reported. The patient reported that he has worked with more COVID patients and is making exposure much manageable. He is not sure if the first dose of the COVID vaccine shot is helping him. The patient is a paramedic and got the first dose of the Covid-19 vaccine 8 days ago and yesterday was diagnosed with the COVID virus. He was tested positive with COVID. The patient wanted to know if it safe to get the second dose or does he have to wait. He said that he was diagnosed with Covid-19 about 20:00 last night 11Jan2021. He said that last night, 11Jan2021, he had a horrible fever. He felt so bad last night that he can't remember much about last night. He stated that the vaccine works. His medical director said that that evidence shows that even with 1 dose if you get the Covid virus, the effects are a lot less. He said that the effects of COVID that he is experiencing are very mild except when the fever spikes. He said that the fevers started early Friday evening (08Jan2021). He said that they started out mild and hit him pretty good on Sunday (11Jan2021). He said that the fever came on midday Sunday and midday yesterday at 15:00, it showed up with a vengeance. He went from normal to 100.3 in a matter of about 5 seconds. He stated that the fevers are off and on. He stated that when his back starts to hurt he knows he is running a fever. Outcome of the events was unknown.   Information on Lot/Batch number has been requested.
Fever, chills, shakes approximately 13 hours after shot. Lasted for an hour until asleep. No issues in the morning.
14-15 days post MMR, morbilliform rash forms on face, then extends to chest, back, buttocks and sporadic on limbs. Low grade fever, runny nose on day 3 of rash. End of day 3, beg of day 4, rash fading.
Dizziness, NauseaVomiting, Pain/Discomfort at injection site Narrative:
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The patients were vaccinated with improperly stored doses of ROTATEQ (lot#, expiration date, strength, dose and route not reported). No symptoms reported. The improperly stored doses were administered 27-AUG-2014 and 28-AUG-2014. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Minor case of Shingles; Frozen Shoulder; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Minor case of Shingles) and PERIARTHRITIS (Frozen Shoulder) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Minor case of Shingles) and PERIARTHRITIS (Frozen Shoulder). At the time of the report, HERPES ZOSTER (Minor case of Shingles) and PERIARTHRITIS (Frozen Shoulder) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 25-Feb-2021: follow up added On 12-May-2021: ADR
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with the improperly stored doses of VAQTA (lot # reported as M047648, expiration date 28-OCT-2017 and lot # M022924 expiration date 24-JAN-2018) dose and route of administration were not reported for prophylaxis. There were no adverse effects reported. Administered doses of vaccines experienced the temperature excursion of 47 to 77 degrees Fahrenheit for 15 minutes. Data logger was involved. There were no previous excursions reported. This is one of three reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA010673: US-009507513-1704USA002375.
Two days after vaccination patient developed fever and boils (4) on neck and chin along with feelings of fatigue. She states she did not take temperature. After one week she developed "severe joint pain in the right hip and leg"  She states she was able to function, did not seek medical advice but she has never had a pain so bad. She took tylenol which helped her feverish feeling but did not relieve the joint pain.
Patient had itching and raised bumps that started on top of left foot that spread to entire body, bumps still present 4 mos. post vaccination.
pt recvd vax; tues 2am started fever & rt arm started to swell;at 1pm tues fever 106 & at that time had convuls; adm to hosp;
Individual pink macules with slightly papular becoming confluent on thighs, over entire body-Rash x 24hrs. began in sm. patches and then spread. BENADRYL and MORTIN given for Tx as needed.
Pt is a healthcare provider, was given seasonal influenza vaccine by workplace employee health, subsequently developed discomfort in the shoulder (particularly abduction above 80-90 deg) unrelieved by OTC analgesics, ice, and rest as recommended by myself (occupational med and workcomp provider) on 10/22 when she initially presented for evaluation. Currently has initiated physical therapy.
Exactly 12 hours from receiving my booster shot I experienced rapid heartbeat, shortness of breath, dizziness, fever, sore arm, swollen and painful lymph nodes under injected arm, bad dry mouth. Every two hours I was drinking bottles of Gatorade to lessen the symptoms.
Exactly 1 week after my first dose of Moderna in exactly the same area vaccinated my right arm started itching. The following morning I woke up to the area swollen  and reddish arm . It does not hurt just experiencing a lot of itchiness.
This spontaneous case, initially received from the nurse on 07-Nov-2017, concerning an unspecified male patient of an unknown age. The patient was not allergic to any of the vaccine's components and was healthy on the date of the vaccine administration. The patient's concomitant medication was not reported. On 02-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 00444611A, expiry date: 13-Jun-2018). On the same day of vaccination 10 min after vaccination, the patient experienced numbness and tingling effect in left hand, chest and on eyes. At the time of this report, the outcome of events not reported. The reporter assessed this case as non-serious. Non-significant follow-up received on 11-Dec-2017: No new information was available. Hence, no updates were made to the narrative.
Eyes turned red and puffed up and built of infection of inner eye, Steroids' drops, week later more drops, month later came back again different stronger drops, still not going away. If I don't take the drops after about 3 days puffs back up again and turn red. Eyes are sensitive to light,
FATIGUE, CHILLS, SITE PAIN/SWELLING, VERY SHORT-RESOLVED COUGH/RUNNY NOSE/SORETHROAT Narrative:
A physician reported the occurrence of injection site cellulitis in a 4-year-old female who received diptheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix). The reporter submitted a report directly to VAERS (VAERS ID, 185346). The pt's medical history, concurrent conditions and concurrent medications were not provided. On an unspecified date, the pt received an injection of Infanrix. On 05/02/2002 post-immunization the pt developed cellulitis at the injection site. The physician prescribed an unspecified antibiotic. The event was reported to have resolved on 05/04/2002. The reporter considered the event to be possibly related to Infanrix immunization.
Information has been received from a physician concerning a 9 year old male who on 02-JAN-2002 and 05-JAN-2005 was vaccinated with the first and second doses of MMR II.  On 08-DEC-2009 the patient experienced mumps.  At the time of this report the patient's status was unknown.  Follow up information has been received from a physician reported that on 04-NOV-2009 the patient experienced mumps.  On 04-NOV-2009 the patient was diagnosed with mumps and was afebrile, it was also reported that the patient was 11 years old at the time of onset.  On 04-NOV-2009 the patient had the first blood work, serum immunoglobulin G is 9.39, serum immunoglobulin M<1:10.  Additional information has been requested.
Injection site turned red and became itchy and patient developed hoarseness within a few minutes of injection.  Received Benadryl onsite that resolved itching.  4 days later patient still hoarse, chronic tinnitus worse, pain in right kidney, fatigue.
Pain in right leg, immediately after shot. Next day doctor, then to E.R. It is cellulitis. I.V. antibiotic. Stayed over nite - taking antibiotic.
Sudden onset severe vertigo - with nausea/vomiting, + nastagmus. No prior history.
sudden onset lower lip angioedema- only on the right side of my lip; This is a spontaneous report from a contactable Other HCP. This other HCP reported different events for the same patient during diffferient vaccination dose. This case is referred to the second vaccine dose A 30-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number EL3247 intramuscular on 13Jan2021 12:30 second dose at SINGLE DOSE for covid-19 immunisation. Facility type vaccine: Hospital . Vaccine location: right arm Medical history included asthma, eczema, hypersensitivity, anxiety and depression. Concomitant medication included ethinylestradiol, norethisterone acetate (JUNEL FE 1/20), bupropion hydrochloride (WELLBUTRIN XL), fluoxetine hydrochloride (PROZAC), rizatriptan (RIZATRIPTAN), salbutamol sulfate (ALBUTEROL [SALBUTAMOL SULFATE]), fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]), levocetirizine dihydrochloride (XYZAL), betamethasone (BETAMETHASONE). The patient previously took aspirin and experienced rash. The patient experienced flushing, palpitations and hyperhidrosis after the first dose of bnt162b2 vaccine. The patient experienced sudden onset lower lip angioedema- only on the right side of my lip on 16Jan2021 20:30 with outcome of recovered. The action taken was not applicable. Therapeutic measures were taken: benadryl  inhaler self treated, consultation w/allergist and allergy testing. The reporter stated "developed sudden onset lower lip angioedema only on the right side of my lip. I took 50mg benadryl and my inhaler and monitored- I never developed itching, additional swelling, difficulty breathing or other symptoms of anaphylaxis. Swelling had resolved by morning. I had no other new exposures that have yet been identified, although I am going through a work up with an allergist."; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021073355 Same patient/ drug, different dose/AE.
Fever 103.5 Chills Whole body aches Weakness Cough Runny and stuffy nose Headache
Vaccines at 1200 evening T 103.8 - Acute belly pain restless sleep. Delirium decreased appetite today.
Pt was given flu vaccines and a few minutes later developed rash/ hives. No angioedema, no respiratory distress or wheezing. Pt given Benadryl and Prednisolone. Pt observed for 1 hr sx did not evolve or worsen. Pt d/c home with rx for Benadryl and Prednisolone. Dr. spoke with mother on 10/13/17 and rash resolved after office visit on 10/12/17 no further sx.
It was reported that a 59 year old male pt received Fluzone (U0922AA) on 11/13/02. Route/site of administration was not reported. The pt developed a sore arm the first 24 hrs and reportedly subsided. On 11/16/02, a bilateral axillary rash began to develop, itchy and red, extended from the center of the armpit 6 inches down to the center of the body 6 inches upwards towards the biceps. The pt denied of any new product use. Pt has no allergies to eggs and thimerosal, but has history of hypertension.
Pain at injection site.  103.6 fever by midday Sunday.  Muscle aches, lack of energy.
8/14/07 Erythema around MMR site. slight fever. Erythema started small Presented 8/15/07 with 6" x 3.5" area of erythema, 10W grade fever. CBC and CRP normal.
feeling achy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 06Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: PAIN (non-serious), outcome "unknown", described as "feeling achy". Additional Information: Patient had the second dose on 06Apr2021. He is feeling achy.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
2 mo old mistakenly given Boosterix (Tdap) at 2 mo well child visit instead of Daptacel (DTaP). No known adverse effects reported.
Left hand swelling and contracture 01/12/07-records received and reviewed for DOS 11-7-07-1-//9-07 C/O contractures mostly of upper extremities. Recent UTI,  PE: exhibits considerable contractures to left wrist and hand as well as right arm.   Ten days after flu shot complained of contractures to wrists, muscle pain in shoulders arms legs and back, headaches. Psychiatric medications increased and rigidity got worse. Medication decreased and contractions in wrists are present. RX with levaquin for UTI. Assessment, unsure if contractures are due to Flu shot no longer believes it is from medications. Plan for neurology consult in near future. Pt moved to another facility.
Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient was very nervous in the vaccination room prior to administration. Patient fainted within 2 minutes of receiving vaccine while sitting and talking to vaccinating technician. Technician and patient's girlfriend safely lowered patient to lay down on floor where he regained consciousness approximately 45 seconds-1min later on his own. No other medications administered. Remained under observation for an additional 30 mins then left with girlfriend.
R knee pain and effusion 1 week after receiving the vaccine; R knee pain and effusion 1 week after receiving the vaccine; This is a spontaneous report from a contactable physician.  A 52-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0104), intramuscular at the left arm on 23Dec2020 12:00 at a single dose for COVID-19 immunization at a hospital in an emergency room/department or urgent care.  Medical history included hypothyroidism, allergies with sulfa.  The patient's concomitant medications were not reported.  The patient experienced right knee pain and effusion 1 week after receiving the vaccine on 30Dec2020, 06:00. The patient an unspecified NSAIDS as a treatment for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications the patient received within 2 weeks. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for it since the vaccination. The patient has not recovered from the events.
Systemic: Rash (other than injection site)-Mild; symptoms lasted 0 days
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 14-DEC-2018, the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # R001529, expiration date 07-NOV-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccine was exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
Headache, Arthralgia, Fever, CHILLS, MOOD DOWN Narrative:
Had pain in my right ribs the day following the vaccination. Later that afternoon I discovered a rash around my right ribs and nearby back. Was diagnosed with Shingles in a telemedicine doctor?s visit sponsored by my insurance plan and she prescribed Valtrex. The rash and pain due to the shingles lasted nearly 2 weeks.
Patient experienced a mild feeling of her heart beating fast for 1-2 minutes.  Vitals were unremarkable when checked by RN.
herpes zoster; Initial information has been received from a lawyer, regarding a case in litigation, and refers to a patient (pt) of unknown gender who at the time of vaccination with zoster vaccine live (ZOSTAVAX) was approximately 66 years old. No information about the pt's medical history, concurrent conditions or concomitant medications was provided. On or about 26-JUL-2012, the pt was administered zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) for the long-term prevention of shingles and zoster-related conditions. Subsequently, on an unknown date, the pt was treated by healthcare providers for the following injuries resulting from the pt's zoster vaccine live (ZOSTAVAX) use: herpes zoster. The outcome of the event was not provided. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, MILD MATERNAL DELIVERY OUTCOME, SINGLETON BIRTH, LIVEBORN